Adverse events76

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 76

Type	Event	Organ system	Group	Affected	At risk
other	Anaemia	Blood and lymphatic system disorders	CS-7017 Plus Erlotinib	16	44
other	Anaemia	Blood and lymphatic system disorders	Erlotinib	3	45
other	Death	General disorders	CS-7017 Plus Erlotinib	4	44
other	Death	General disorders	Erlotinib	1	45
other	Disease progression	General disorders	CS-7017 Plus Erlotinib	8	44
other	Disease progression	General disorders	Erlotinib	5	45
other	Fatigue	General disorders	CS-7017 Plus Erlotinib	9	44
other	Fatigue	General disorders	Erlotinib	5	45
other	Neutrophil count decreased	Investigations	CS-7017 Plus Erlotinib	3	44
other	Neutrophil count decreased	Investigations	Erlotinib	0	45
other	Any Blood and Lymphatic System Disorders	Blood and lymphatic system disorders	CS-7017 Plus Erlotinib	18	44
other	Any Blood and Lymphatic System Disorders	Blood and lymphatic system disorders	Erlotinib	4	45
other	Any Cardiac Disorders	Cardiac disorders	CS-7017 Plus Erlotinib	7	44
other	Any Cardiac Disorders	Cardiac disorders	Erlotinib	2	45
other	Any General Disorders & Administration Site Conditions	General disorders	CS-7017 Plus Erlotinib	41	44
other	Any General Disorders & Administration Site Conditions	General disorders	Erlotinib	19	45
other	Any Investigations	Investigations	CS-7017 Plus Erlotinib	15	44
other	Any Investigations	Investigations	Erlotinib	12	45
other	Any Neoplasms Benign, Malignant, and Unspecified (Including Cysts and Polyps)	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	CS-7017 Plus Erlotinib	4	44
other	Any Neoplasms Benign, Malignant, and Unspecified (Including Cysts and Polyps)	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	Erlotinib	2	45

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01101334/events

API reference For AI assistants

Adverse events76

Sources 3

Read this list from software.